6533b833fe1ef96bd129b751

RESEARCH PRODUCT

Simultaneous appearance of leukemoid reaction and phlegmasia cerulea dolens

Zoran RancicP KovačevićT KovačevićFelice Pecoraro

subject

Malemedicine.medical_specialtyNeutrophil granulocyte610 Medicine & healthGastroenterologySettore MED/22 - Chirurgia Vascolare2705 Cardiology and Cardiovascular MedicineLeukocyte CountInternal medicineWhite blood cellmedicineHumansGeneral anaesthesiaLeukocytosisAgedPhlegmasia cerulea dolensphlegmasia cerulea dolenHematomabusiness.industryRemission InductionThrombosisGeneral MedicineThrombophlebitismedicine.diseaseThrombosisSystemic Inflammatory Response Syndromeleukemoid reaction10020 Clinic for Cardiac SurgerySurgerySystemic inflammatory response syndromemedicine.anatomical_structurephlegmasia cerulea dolens; leukemoid reactionmedicine.symptomCardiology and Cardiovascular MedicinebusinessLeukemoid reaction

description

A leukemoid reaction is an extreme form of reactive leukocytosis defined as granulocytic leukocytosis above 50 × 109/L produced by normal bone marrow, mostly in response to systemic infection or cancer. The mechanism as to how the haematopoetic system is altered to elevate production of myeloid cells is not known. A 69-year-old man presented with phlegmasia cerulea dolens caused by massive iliofemoral thrombosis. His workout at admission revealed absolute white blood cell count of 73.4 × 109/L, with neutrophil granulocyte of 68.5 × 109/L. The new increase in white blood cell count happened at day 5 after admission, when the haematoma of the anteromedial thigh was evacuated in general anaesthesia. There was a gradual decrease in counts until they reached the normal range. Deteriorated general condition with signs of systemic inflammatory response syndrome improved with supportive therapy, and the patient was discharged from hospital after 30 days. During hospitalization we did not identify any infectious focus, or any malignancy. We could not exclude other occult chronic conditions (malignancy) but the patient did not develop any other condition during 4.5 years of follow-up.

10.1258/phleb.2011.011041http://hdl.handle.net/10447/99631